Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice

British Journal of Pharmacology

Volumn 136, Issue 3, 2002, Pages 415-420

  Wegener, J W ^a   Godecke A ^b   Schrader, J ^b   Nawrath, H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Force of contraction; Guanylyl cyclase; Heart muscle; Myoglobin; Nitric oxide

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; DIMETHYL SULFOXIDE; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; MYOGLOBIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; SODIUM 1 (N,N DIETHYLAMINO)DIAZEN 1 IUM 1,2 DIOLATE; UNCLASSIFIED DRUG; 1,1 DIETHYL 2 HYDROXY 2 NITROSOHYDRAZINE; 1,1-DIETHYL-2-HYDROXY-2-NITROSOHYDRAZINE; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 2,2' (HYDROXYNITROSOHYDRAZONO)BIS ETHANAMINE; 2,2'-(HYDROXYNITROSOHYDRAZONO)BIS-ETHANAMINE; ENZYME INHIBITOR; HYDRAZINE DERIVATIVE; NITRIC OXIDE DONOR; NITROGEN OXIDE; NITROSO DERIVATIVE; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; MALE; MOUSE; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; ANIMAL; COMPARATIVE STUDY; ELECTROSTIMULATION; ENZYMOLOGY; GENETICS; IN VITRO STUDY;

ANIMAL; COMPARATIVE STUDY; ELECTRIC STIMULATION; ENZYME INHIBITORS; FEMALE; HYDRAZINES; IN VITRO; MALE; MICE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOGLOBIN; NITRIC OXIDE DONORS; OXADIAZOLES; QUINOXALINES; S-NITROSO-N-ACETYLPENICILLAMINE; SUPPORT, NON-U.S. GOV'T; ANIMALS; NITROGEN OXIDES; NITROSO COMPOUNDS;

EID: 0036016112     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704740     Document Type: Article

References (36)

1. G protein-mediated inhibitory effect of a nitric oxide donor on the L- type Ca2+ current in rat ventricular myocytes
2. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain
3. Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2+ sources
4. The soluble guanylyl cyclase inhibitor 1H-[1, 2, 4]oxadiazolo[4, 3, -a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation
5. The ins and outs of caveolar signaling. M2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes
6. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility
7. Myoglobin: A scavenger of bioactive NO
8. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one
9. Disruption of myoglobin in mice induces multiple compensatory mechanisms
10. S-nitrosothiols as vasodilators: Implications regarding tolerance to nitric oxide-containing vasodilators
11. Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle
12. Regulation of the L-type Ca2+ channel during cardiomyogenesis: Switch from NO to adenylyl cyclase-mediated inhibition
13. "NONOates" (1-substituted diazen-1-ium-1, 2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
14. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes
15. Selective blockade of endothelium-dependent and glyceryl trinitrate- induced relaxation by hemoglobin and by methylene blue in the rabbit aorta
16. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation
17. Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung
18. Nitric oxide: Physiology, pathophysiology, and pharmacology
19. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators
20. The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium
21. Rapid, simple and sensitive microassay for skeletal and cardiac muscle myoglobin and hemoglobin: Use in various animals indicates functional role of myohemoproteins
22. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes
23. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation
24. Release of nitric oxide from donors with known half-life: A mathematical model for calculating nitric oxide concentrations in aerobic solutions
25. Paracrine and autocrine effects of nitric oxide on myocardial function
26. Factors released from endocardium of the ferret and pig modulate myocardial contraction
27. Nitric oxide reduces energy supply by direct action on the respiratory chain in isolated cardiomyocytes
28. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes
29. Differences in the nitric oxide/soluble guanylyl cyclase signalling pathway in the myocardium of neonatal and adult rats
30. Failure of 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes
31. Cardiac effects of isoliquiritigenin
32. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle
33. S-nitrosothiols and role of metal ions in decomposition to nitric oxide
34. Myoglobin-facilitated oxygen diffusion: Role of myoglobin in oxygen entry into muscle
35. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide
36. Inhibition of soluble guanylate cyclase by ODQ